Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia 12Lymphoma 8Sarcoma 7Leukemia, Myeloid, Acute 6Neuroblastoma 5Kidney Neoplasms 5HIV Infections 5Congenital Abnormalities 5Precancerous Conditions 4Carcinoma, Non-Small-Cell Lung 4Wilms Tumor 3Squamous Cell Carcinoma of Head and Neck 3Papillomavirus Infections 3Lymphoma, Follicular 3Lung Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Intraepithelial Lesions 2Salivary Gland Neoplasms 2Ovarian Neoplasms 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Hodgkin Disease 2Esophageal Neoplasms 2AIDS-related Kaposi sarcoma 2

Interventions

nilotinib 3Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2fludarabine 2bosutinib 2Whole-Body Irradiation 2Tacrolimus 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Imatinib Mesylate 2Dasatinib 2Cyclophosphamide 2Busulfan 2Bone Marrow Transplantation 2plerixafor 1Stem Cell Transplantation 1Saline Solution 1Polymerase Chain Reaction 1Fibroblast Growth Factor 7 1Cytogenetic Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Polymerase Chain Reaction × Clear all
NCT00809211 2018-07-24

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Cancer Trials Ireland

Phase 2 Completed
40 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡